Optimized Antigen Matching - Chances and Challenges in Molecular Times

Overview

Journal Transfus Med Hemother

Specialty Hematology

Date 2018 Oct 5

PMID 30283269

Authors

Christoph Gassner

Franz F Wagner

Affiliations

Soon will be listed here.

References

Wagner F, Doescher A, Bittner R, Muller T . Extended Donor Typing by Pooled Capillary Electrophoresis: Impact in a Routine Setting. Transfus Med Hemother. 2018; 45(4):225-237. PMC: 6158588. DOI: 10.1159/000490155. View

Fichou Y, Mariez M, Le Marechal C, Ferec C . The experience of extended blood group genotyping by next-generation sequencing (NGS): investigation of patients with sickle-cell disease. Vox Sang. 2016; 111(4):418-424. DOI: 10.1111/vox.12432. View

Flegel W, Gottschall J, Denomme G . Integration of red cell genotyping into the blood supply chain: a population-based study. Lancet Haematol. 2015; 2(7):e282-9. PMC: 4508019. DOI: 10.1016/S2352-3026(15)00090-3. View

Chou S, Flanagan J, Vege S, Luban N, Brown R, Ware R . Whole-exome sequencing for genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv. 2018; 1(18):1414-1422. PMC: 5727856. DOI: 10.1182/bloodadvances.2017007898. View

Shao C, Zhao C, Wu C, Xu H, Wang X, Wu X . Rh-Matched Transfusion through Molecular Typing for β-Thalassemia Patients Is Required and Feasible in Chinese. Transfus Med Hemother. 2018; 45(4):252-257. PMC: 6158581. DOI: 10.1159/000489471. View

Gassner C, Degenhardt F, Meyer S, Vollmert C, Trost N, Neuenschwander K . Low-Frequency Blood Group Antigens in Switzerland. Transfus Med Hemother. 2018; 45(4):239-250. PMC: 6158591. DOI: 10.1159/000490714. View

Scharberg E, Rink G, Portegys J, Rothenberger S, Gillhuber N, Richter E . The Impact of Using Genotyped Reagent Red Blood Cells in Antibody Identification. Transfus Med Hemother. 2018; 45(4):218-224. PMC: 6158584. DOI: 10.1159/000491884. View

Khan J, Delaney M . Transfusion Support of Minority Patients: Extended Antigen Donor Typing and Recruitment of Minority Blood Donors. Transfus Med Hemother. 2018; 45(4):271-276. PMC: 6158592. DOI: 10.1159/000491883. View

Floch A, Tournamille C, Chami B, Pirenne F . Genotyping in Sickle Cell Disease Patients: The French Strategy. Transfus Med Hemother. 2018; 45(4):264-270. PMC: 6158580. DOI: 10.1159/000490858. View

10.

Castilho L, Dinardo C . Optimized Antigen-Matched in Sickle Cell Disease Patients: Chances and Challenges in Molecular Times - the Brazilian Way. Transfus Med Hemother. 2018; 45(4):258-262. PMC: 6158589. DOI: 10.1159/000490713. View

11.

Dezan M, Ribeiro I, Oliveira V, Vieira J, Gomes F, Franco L . RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients. Blood Cells Mol Dis. 2017; 65:8-15. DOI: 10.1016/j.bcmd.2017.03.014. View